IMAX CORP·4

Nov 10, 8:28 PM ET

WELTON MARK 4

4 · IMAX CORP · Filed Nov 10, 2025

Insider Transaction Report

Form 4
Period: 2025-11-10
WELTON MARK
President IMAX Global Theatres
Transactions
  • Sale

    common shares

    2025-11-10$35.23/sh49,504$1,743,927153,323 total
  • Conversion

    common shares

    2025-11-10$22.49/sh+49,504$1,113,345202,827 total
  • Conversion

    stock options (to buy)

    2025-11-10$22.49/sh49,504$1,113,3450 total
    Exercise: $22.49Exp: 2026-03-07common shares (49,504 underlying)
Holdings
  • common shares (opening balance)

    153,323
Footnotes (4)
  • [F1]Represents the conversion upon exercise of stock options into common shares.
  • [F2]These options were issued in 2019 and are set to expire on March 7, 2026.
  • [F3]The stock options became exercisable in four installments: 9,900 on March 7, 2020, 12,376 on each of March 7, 2021 and March 7, 2022 and 14,852 on March 7, 2023.
  • [F4]Mr. Welton's aggregate remaining outstanding restricted share unit and common share balances following these transactions will be 70,609 and 153,323, respectively.

Documents

1 file
  • 4
    ownership.xmlPrimary